Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer.

Kudo T, Takemasa I, Hata T, Sakai D, Takahashi H, Haraguchi N, Nishimura J, Hata T, Matsuda C, Satoh T, Mizushima T, Mori M, Doki Y.

Oncology. 2019 Jul 2:1-6. doi: 10.1159/000500677. [Epub ahead of print]

PMID:
31266024
2.

Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma.

Shima H, Tsurita G, Wada S, Hirohashi Y, Yasui H, Hayashi H, Miyakoshi T, Watanabe K, Murai A, Asanuma H, Tokita S, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Nakae Y, Sugita O, Ito YM, Ota Y, Kimura Y, Kutomi G, Hirata K, Mizuguchi T, Imai K, Takemasa I, Sato N, Torigoe T.

Cancer Sci. 2019 Aug;110(8):2378-2385. doi: 10.1111/cas.14106. Epub 2019 Jul 23.

3.

Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series.

Kubo T, Tsurita G, Hirohashi Y, Yasui H, Ota Y, Watanabe K, Murai A, Matsuo K, Asanuma H, Shima H, Wada S, Nakatsugawa M, Kanaseki T, Tsukahara T, Mizuguchi T, Hirata K, Takemasa I, Imai K, Sato N, Torigoe T.

Cancer Sci. 2019 Aug;110(8):2386-2395. doi: 10.1111/cas.14099. Epub 2019 Jul 11.

4.

Central pancreatectomy in portal annular pancreas for metastatic renal cell carcinoma: a case report.

Yamaguchi H, Kimura Y, Nagayama M, Imamura M, Tanaka S, Yoshida M, Yoshida E, Fujino H, Machiki T, Miyanishi K, Mizuguchi T, Kato J, Takemasa I.

World J Surg Oncol. 2019 Apr 30;17(1):76. doi: 10.1186/s12957-019-1622-8.

5.

Current status of site-specific cancer registry system for the clinical researches: aiming for future contribution by the assessment of present medical care.

Hirata K, Imamura M, Fujiwara T, Fukui T, Furukawa T, Gotoh M, Hakamada K, Ishiguro M, Kakeji Y, Konno H, Miyata H, Mori M, Okita K, Sato M, Shibata A, Takemasa I, Unno M, Yokoi K, Nishidate T, Nishiyama M.

Int J Clin Oncol. 2019 Sep;24(9):1161-1168. doi: 10.1007/s10147-019-01434-w. Epub 2019 Apr 22.

PMID:
31011913
6.

Influence of XRCC4 expression by breast cancer cells on ipsilateral recurrence after breast-conserving therapy.

Kitagawa M, Someya M, Hasegawa T, Mikami T, Asaishi K, Hasegawa T, Matsumoto Y, Kutomi G, Takemasa I, Sakata KI.

Strahlenther Onkol. 2019 Jul;195(7):648-658. doi: 10.1007/s00066-019-01468-z. Epub 2019 Apr 17.

PMID:
30997540
7.

Ectopic relapse of IgG4-related disease presenting as IgG4-related sclerosing cholecystitis: A case report and review of literature.

Ishigami K, Shitani M, Kimura Y, Hasegawa T, Masaki Y, Ito A, Akutsu N, Yamamoto M, Motoya M, Sasaki S, Takahashi H, Takemasa I, Nakase H.

Medicine (Baltimore). 2018 Dec;97(52):e13868. doi: 10.1097/MD.0000000000013868.

8.

A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer.

Sato Y, Sagawa T, Ohnuma H, Hirakawa M, Takahashi Y, Hamaguchi K, Fujikawa K, Nobuoka T, Okamoto K, Miyamoto H, Muguruma N, Takemasa I, Takayama T.

Cancer Chemother Pharmacol. 2019 Jan;83(1):161-167. doi: 10.1007/s00280-018-3719-0. Epub 2018 Nov 7.

PMID:
30406285
9.

Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future.

Imamura M, Hirata K, Unno M, Kamiya K, Gotoh M, Konno H, Shibata A, Sugihara K, Takahashi A, Nishiyama M, Hakamada K, Fukui T, Furukawa T, Mizushima T, Mizuma M, Miyata H, Mori M, Takemasa I, Mizuguchi T, Fujiwara T.

Int J Clin Oncol. 2019 Feb;24(2):189-195. doi: 10.1007/s10147-018-1340-1. Epub 2018 Aug 24.

10.

Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.

Ohnuma H, Sato Y, Hayasaka N, Matsuno T, Fujita C, Sato M, Osuga T, Hirakawa M, Miyanishi K, Sagawa T, Fujikawa K, Ohi M, Okagawa Y, Tsuji Y, Hirayama M, Ito T, Nobuoka T, Takemasa I, Kobune M, Kato J.

Cancer Sci. 2018 Nov;109(11):3554-3563. doi: 10.1111/cas.13772. Epub 2018 Sep 25.

11.

Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine.

Shima H, Kutomi G, Satomi F, Imamura M, Kimura Y, Mizuguchi T, Watanabe K, Takahashi A, Murai A, Tsukahara T, Kanaseki T, Hirohashi Y, Iwayama Y, Tsuruma T, Kameshima H, Sato N, Torigoe T, Takemasa I.

Cancer Immunol Immunother. 2018 Oct;67(10):1603-1609. doi: 10.1007/s00262-018-2217-x. Epub 2018 Aug 1.

12.

Local control of sphincter-preserving procedures and abdominoperineal resection for locally advanced low rectal cancer: Propensity score matched analysis.

Okamura R, Hida K, Yamaguchi T, Akagi T, Konishi T, Yamamoto M, Ota M, Matoba S, Bando H, Goto S, Sakai Y, Watanabe M; Japan Society of Laparoscopic Colorectal Surgery, Watanabe K, Otsuka K, Takemasa I, Tanaka K, Ikeda M, Matsuda C, Fukuda M, Hasegawa J, Akamoto S, Shiozawa M, Tsuruta A, Akiyoshi T, Kato T, Tsukamoto S, Ito M, Naito M, Kanazawa A, Takahashi T, Ueki T, Hayashi Y, Morita S, Yamaguchi T, Nakanishi M, Hasegawa H, Okamoto K, Teraishi F, Sumi Y, Tashiro J, Yatsuoka T, Nishimura Y, Okita K, Kobatake T, Horie H, Miyakura Y, Ro H, Nagakari K, Hidaka E, Umemoto T, Nishigori H, Murata K, Wakayama F, Makizumi R, Fujii S, Sunami E, Kobayashi H, Nakagawa R, Enomoto T, Ohnuma S, Higashijima J, Ozawa H, Ashida K, Fujita F, Uehara K, Maruyama S, Ohyama M, Yamamoto S, Hinoi T, Yoshimitsu M, Okajima M, Tanimura S, Kawasaki M, Ide Y, Hazama S, Watanabe J, Inagaki D, Toyokawa A.

Ann Gastroenterol Surg. 2017 Aug 14;1(3):199-207. doi: 10.1002/ags3.12032. eCollection 2017 Sep.

13.

MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer.

Ishigami K, Nosho K, Koide H, Kanno S, Mitsuhashi K, Igarashi H, Shitani M, Motoya M, Kimura Y, Hasegawa T, Kaneto H, Takemasa I, Suzuki H, Nakase H.

Carcinogenesis. 2018 Sep 21;39(9):1127-1134. doi: 10.1093/carcin/bgy075.

PMID:
29860474
14.

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J.

Lancet. 2018 May 26;391(10135):2128-2139. doi: 10.1016/S0140-6736(18)30789-X. Epub 2018 May 10.

PMID:
29754777
15.

Comparison of surgical outcomes and complications between the Harmonic FOCUS and conventional surgery for open thyroidectomy.

Maeda H, Kutomi G, Satomi F, Shima H, Mori M, Takemasa I.

Mol Clin Oncol. 2018 Apr;8(4):557-560. doi: 10.3892/mco.2018.1569. Epub 2018 Feb 7.

16.

Laparoscopic surgery using a Gigli wire saw for locally recurrent rectal cancer with concomitant intraperitoneal sacrectomy.

Uemura M, Ikeda M, Kawai K, Nishimura J, Takemasa I, Mizushima T, Yamamoto H, Sekimoto M, Doki Y, Mori M.

Asian J Endosc Surg. 2018 Feb;11(1):83-86. doi: 10.1111/ases.12407.

PMID:
29485249
17.

Validation of the Japanese Version of the Low Anterior Resection Syndrome Score.

Akizuki E, Matsuno H, Satoyoshi T, Ishii M, Usui A, Ueki T, Nishidate T, Okita K, Mizushima T, Mori M, Takemasa I.

World J Surg. 2018 Aug;42(8):2660-2667. doi: 10.1007/s00268-018-4519-8.

18.

Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study.

Ohnuma H, Sato Y, Hirakawa M, Kikuchi S, Miyanishi K, Sagawa T, Takahashi Y, Nobuoka T, Okamoto K, Miyamoto H, Takemasa I, Takayama T, Kato J.

Cancer Chemother Pharmacol. 2018 Mar;81(3):539-548. doi: 10.1007/s00280-018-3523-x. Epub 2018 Jan 30.

PMID:
29383482
19.

The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer.

Miyamoto S, Kochin V, Kanaseki T, Hongo A, Tokita S, Kikuchi Y, Takaya A, Hirohashi Y, Tsukahara T, Terui T, Ishitani K, Hata F, Takemasa I, Miyazaki A, Hiratsuka H, Sato N, Torigoe T.

Cancer Immunol Res. 2018 Mar;6(3):358-369. doi: 10.1158/2326-6066.CIR-17-0518. Epub 2018 Jan 25.

20.

ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway.

Ogawa T, Hirohashi Y, Murai A, Nishidate T, Okita K, Wang L, Ikehara Y, Satoyoshi T, Usui A, Kubo T, Nakastugawa M, Kanaseki T, Tsukahara T, Kutomi G, Furuhata T, Hirata K, Sato N, Mizuguchi T, Takemasa I, Torigoe T.

Oncotarget. 2017 Nov 8;8(68):112550-112564. doi: 10.18632/oncotarget.22545. eCollection 2017 Dec 22.

21.

Clinical benefits of single-incision laparoscopic surgery for postoperative delirium in elderly colon cancer patients.

Nishizawa Y, Hata T, Takemasa I, Yamasaki M, Akasaka H, Sugimoto K, Tamai K, Takahashi H, Haraguchi N, Nishimura J, Matsuda C, Mizushima T, Ikenaga M, Yamamoto H, Murata K, Rakugi H, Doki Y, Mori M.

Surg Endosc. 2018 Mar;32(3):1434-1440. doi: 10.1007/s00464-017-5827-z. Epub 2017 Oct 26.

PMID:
29075972
22.

A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study.

Sato Y, Hirakawa M, Ohnuma H, Takahashi M, Okamoto T, Okamoto K, Miyamoto H, Muguruma N, Furuhata T, Takemasa I, Kato J, Takayama T.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1133-1139. doi: 10.1007/s00280-017-3458-7. Epub 2017 Oct 16.

PMID:
29038850
23.

The Author Replies.

Miyo M, Takemasa I, Ishihara H, Hata T, Mizushima T, Ohno Y, Doki Y, Mori M.

Dis Colon Rectum. 2017 Nov;60(11):e631-e632. doi: 10.1097/DCR.0000000000000938. No abstract available.

PMID:
28991091
24.

Inspection of Perirectal Lymph Nodes by One-Step Nucleic Acid Amplification Predicts Lateral Lymph Node Metastasis in Advanced Rectal Cancer.

Miyake Y, Mizushima T, Hata T, Takahashi H, Hanada H, Shoji H, Nomura M, Haraguchi N, Nishimura J, Matsuda C, Takemasa I, Doki Y, Maeda I, Mori M, Yamamoto H.

Ann Surg Oncol. 2017 Dec;24(13):3850-3856. doi: 10.1245/s10434-017-6069-y. Epub 2017 Sep 18.

PMID:
28924845
25.

Safety and Feasibility of Umbilical Diverting Loop Ileostomy for Patients with Rectal Tumor.

Miyo M, Takemasa I, Hata T, Mizushima T, Doki Y, Mori M.

World J Surg. 2017 Dec;41(12):3205-3211. doi: 10.1007/s00268-017-4128-y.

PMID:
28748422
26.

Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG).

Miyake Y, Nishimura J, Kato T, Ikeda M, Tsujie M, Hata T, Takemasa I, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M; Multi-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).

Surg Today. 2018 Jan;48(1):66-72. doi: 10.1007/s00595-017-1555-1. Epub 2017 Jun 20.

PMID:
28634730
27.

Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer.

Hata T, Takemasa I, Takahashi H, Haraguchi N, Nishimura J, Hata T, Mizushima T, Doki Y, Mori M.

Br J Cancer. 2017 Jul 11;117(2):227-232. doi: 10.1038/bjc.2017.163. Epub 2017 Jun 20.

28.

Long-term Outcomes of Single-Site Laparoscopic Colectomy With Complete Mesocolic Excision for Colon Cancer: Comparison With Conventional Multiport Laparoscopic Colectomy Using Propensity Score Matching.

Miyo M, Takemasa I, Ishihara H, Hata T, Mizushima T, Ohno Y, Doki Y, Mori M.

Dis Colon Rectum. 2017 Jul;60(7):664-673. doi: 10.1097/DCR.0000000000000810.

PMID:
28594715
29.

Neoadjuvant CapeOx therapy followed by sphincter-preserving surgery for lower rectal cancer.

Hata T, Takahashi H, Sakai D, Haraguchi N, Nishimura J, Kudo T, Chu M, Takemasa I, Taroh S, Mizushima T, Doki Y, Mori M.

Surg Today. 2017 Nov;47(11):1372-1377. doi: 10.1007/s00595-017-1527-5. Epub 2017 May 4.

PMID:
28474202
30.

Adipose-Derived Stem Cells Ameliorate Experimental Murine Colitis via TSP-1-Dependent Activation of Latent TGF-β.

Takeyama H, Mizushima T, Uemura M, Haraguchi N, Nishimura J, Hata T, Matsuda C, Takemasa I, Ikenaga M, Murata K, Yamamoto H, Doki Y, Mori M.

Dig Dis Sci. 2017 Aug;62(8):1963-1974. doi: 10.1007/s10620-017-4578-y. Epub 2017 Apr 22.

PMID:
28434074
31.

Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative "Adaptive Immune Escape" Phenomenon.

Kubo T, Hirohashi Y, Matsuo K, Sonoda T, Sakamoto H, Furumura K, Tsukahara T, Kanaseki T, Nakatsugawa M, Hirano H, Furuhata T, Takemasa I, Hasegawa T, Torigoe T.

Anticancer Res. 2017 Mar;37(3):1289-1295.

PMID:
28314294
32.

The influence of specific technical maneuvers utilized in the creation of diverting loop-ileostomies on stoma-related morbidity.

Miyo M, Takemasa I, Ikeda M, Tujie M, Hasegawa J, Ohue M, Kato T, Mizushima T, Doki Y, Mori M.

Surg Today. 2017 Aug;47(8):940-950. doi: 10.1007/s00595-017-1481-2. Epub 2017 Mar 9.

PMID:
28280983
33.

LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.

Wang L, Hirohashi Y, Ogawa T, Shen M, Takeda R, Murai A, Yamamoto E, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Nishidate T, Okita K, Kutomi G, Sato N, Takemasa I, Torigoe T.

Biochem Biophys Res Commun. 2017 Apr 29;486(2):232-238. doi: 10.1016/j.bbrc.2017.02.112. Epub 2017 Feb 24.

PMID:
28238780
34.

Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.

Takeda R, Hirohashi Y, Shen M, Wang L, Ogawa T, Murai A, Yamamoto E, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Nishidate T, Okita K, Kutomi G, Sato N, Takemasa I, Torigoe T.

Biochem Biophys Res Commun. 2017 Apr 8;485(3):651-657. doi: 10.1016/j.bbrc.2017.02.081. Epub 2017 Feb 20.

PMID:
28219643
35.

Role of pulmonary metastasectomy in colorectal cancer in the era of modern multidisciplinary therapy.

Kanzaki R, Inoue M, Kimura T, Kawamura T, Funaki S, Shintani Y, Minami M, Takemasa I, Mizushima T, Mori M, Okumura M.

Surg Today. 2017 Sep;47(9):1111-1118. doi: 10.1007/s00595-017-1478-x. Epub 2017 Feb 15.

PMID:
28205021
36.

MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.

Kanno S, Nosho K, Ishigami K, Yamamoto I, Koide H, Kurihara H, Mitsuhashi K, Shitani M, Motoya M, Sasaki S, Tanuma T, Maguchi H, Hasegawa T, Kimura Y, Takemasa I, Shinomura Y, Nakase H.

Carcinogenesis. 2017 Apr 1;38(4):425-431. doi: 10.1093/carcin/bgx013.

PMID:
28186267
37.

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics.

Yamamoto I, Nosho K, Kanno S, Igarashi H, Kurihara H, Ishigami K, Ishiguro K, Mitsuhashi K, Maruyama R, Koide H, Okuda H, Hasegawa T, Sukawa Y, Okita K, Takemasa I, Yamamoto H, Shinomura Y, Nakase H.

Oncotarget. 2017 Mar 14;8(11):17810-17818. doi: 10.18632/oncotarget.14863.

38.

Tumor Size as an Independent Risk Factor for Postoperative Complications in Laparoscopic Low Anterior Resection for Advanced Rectal Cancer: A Multicenter Japanese Study.

Yasui M, Takemasa I, Miyake Y, Hata T, Ikeda M, Miyake Y, Hasegawa J, Ota H, Matsuda C, Mizushima T, Doki Y, Mori M; Clinical Study Group of Osaka University (CSGO), Colorectal Group.

Surg Laparosc Endosc Percutan Tech. 2017 Apr;27(2):98-103. doi: 10.1097/SLE.0000000000000377.

PMID:
28141746
39.

The single-center experience with the standardization of single-site laparoscopic colectomy for right-sided colon cancer.

Takahashi H, Takemasa I, Haraguchi N, Nishimura J, Hata T, Yamamoto H, Matsuda C, Mizushima T, Doki Y, Mori M.

Surg Today. 2017 Aug;47(8):966-972. doi: 10.1007/s00595-016-1457-7. Epub 2016 Dec 20.

PMID:
27999950
40.

The importance of mitochondrial folate enzymes in human colorectal cancer.

Miyo M, Konno M, Colvin H, Nishida N, Koseki J, Kawamoto K, Tsunekuni K, Nishimura J, Hata T, Takemasa I, Mizushima T, Doki Y, Mori M, Ishii H.

Oncol Rep. 2017 Jan;37(1):417-425. doi: 10.3892/or.2016.5264. Epub 2016 Nov 22.

PMID:
27878282
41.

Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer.

Kitahara T, Haraguchi N, Takahashi H, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.

Ann Surg Oncol. 2017 Apr;24(4):1110-1119. doi: 10.1245/s10434-016-5671-8. Epub 2016 Nov 10.

PMID:
27834032
42.

Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity.

Munakata K, Uemura M, Tanaka S, Kawai K, Kitahara T, Miyo M, Kano Y, Nishikawa S, Fukusumi T, Takahashi Y, Hata T, Nishimura J, Takemasa I, Mizushima T, Ikenaga M, Kato T, Murata K, Carethers JM, Yamamoto H, Doki Y, Mori M.

Clin Cancer Res. 2016 Nov 1;22(21):5277-5286. Epub 2016 May 10.

43.

[Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.

Yamamoto H, Oshiro R, Ohtsuka M, Uemura M, Haraguchi N, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M.

Int J Oncol. 2016 Nov;49(5):2186. doi: 10.3892/ijo.2016.3694. Epub 2016 Sep 16.

44.

The short-term outcomes of laparoscopic multivisceral resection for locally advanced colorectal cancer: our experience of 39 cases.

Miyake Y, Nishimura J, Takahashi H, Haraguchi N, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.

Surg Today. 2017 May;47(5):575-580. doi: 10.1007/s00595-016-1429-y. Epub 2016 Oct 21.

PMID:
27770208
45.

Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study.

Akita H, Ritchie SA, Takemasa I, Eguchi H, Pastural E, Jin W, Yamazaki Y, Goodenowe DB, Nagano H, Monden M, Mori M, Doki Y.

Pancreas. 2016 Nov;45(10):1418-1423.

PMID:
27518463
46.

Clinicopathological characteristics of thyroid cancer misdiagnosed by fine needle aspiration.

Maeda H, Kutomi G, Satomi F, Shima H, Mori M, Hirata K, Takemasa I.

Exp Ther Med. 2016 Oct;12(4):2766-2772. Epub 2016 Sep 1.

47.

Safety and efficacy of an "enhanced recovery after surgery" protocol for patients undergoing colon cancer surgery: a multi-institutional controlled study.

Ota H, Ikenaga M, Hasegawa J, Murata K, Miyake Y, Mizushima T, Hata T, Takemasa I, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M.

Surg Today. 2017 Jun;47(6):668-675. doi: 10.1007/s00595-016-1423-4. Epub 2016 Sep 29.

PMID:
27688031
48.

Erratum to: Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.

Sato Y, Ohnuma H, Nobuoka T, Hirakawa M, Sagawa T, Fujikawa K, Takahashi Y, Shinya M, Katsuki S, Takahashi M, Maeda M, Okagawa Y, Naoki U, Kikuch S, Okamoto K, Miyamoto H, Shimada M, Takemasa I, Kato J, Takayama T.

Gastric Cancer. 2017 May;20(3):527. doi: 10.1007/s10120-016-0643-z. No abstract available.

PMID:
27629880
49.

Long-term outcome of adrenalectomy for metastasis resulting from colorectal cancer with other metastatic sites: A report of 3 cases.

Uemura M, Kim HM, Ikeda M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.

Oncol Lett. 2016 Sep;12(3):1649-1654. Epub 2016 Jul 21.

50.

Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.

Sato Y, Ohnuma H, Nobuoka T, Hirakawa M, Sagawa T, Fujikawa K, Takahashi Y, Shinya M, Katsuki S, Takahashi M, Maeda M, Okagawa Y, Naoki U, Kikuch S, Okamoto K, Miyamoto H, Shimada M, Takemasa I, Kato J, Takayama T.

Gastric Cancer. 2017 May;20(3):517-526. doi: 10.1007/s10120-016-0633-1. Epub 2016 Aug 23. Erratum in: Gastric Cancer. 2017 May;20(3):527.

PMID:
27553665

Supplemental Content

Loading ...
Support Center